Figure 4.
ROC curve analyses. (A) The sensitivity and specificity of primary lesions SUVmax for predicting the presence of EGFR mutations in patients with NSCLC. (B) Sensitivity and specificity of CEA value for predicting the presence of EGFR mutations in patients with NSCLC. (C) Sensitivity and specificity of metastatic lymph nodes SUVmax for predicting the presence of EGFR mutations in patients with NSCLC. (D) Comparative ROC curves of various factors for predicting EGFR mutation. EGFR, epidermal growth factor receptor; SUVmax, maximum standardized uptake value; CEA, carcinoembryonic antigen; 18F-FDG PET/CT; SUVmax(T), SUVmax in primary lesions; SUVmax(N), SUVmax in metastatic lymph nodes; NSCLC, non-small cell lung cancer; ROC, receiver operating characteristic.